Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

This study is testing whether adding a new drug called TQB3616 to standard hormone therapy can help control advanced breast cancer that has stopped responding to commonly used CDK4/6 inhibitor medications. The trial involves 33 women whose cancer has returned or spread despite pr…